Prudence Okeke is 17-year-old who identifies as

Prudence Okeke is 17-year-old who identifies as female. She has been admitted to the Medical Unit (MU) where you are on placement. Her presenting complaint is a productive cough, shortness of breath and fever for the past 2 days which developed while she was recovering from insertion of pins for a compound fracture of her right radius, while an inpatient on the Surgical Unit. Please note she is right-hand dominant. She has tested Covid 19 negative. Her primary diagnosis for this admission is Hospital Acquired Pneumonia. Sputum specimens have been sent for microscopy culture and sensitivity (MC & S) and the organism has been identified. Her past medical history is Diabetes Mellitus type 1 which was diagnosed when she was 10 years of age. Prior to admission she self-administered her medication. Her insulin regime includes NovoRapid ® 3 units subcutaneously, via NovoPen ® , to be administered 20 minutes before meals (or adjusted by carbohydrate coverage ratio adjustments). She is also prescribed a basal dose of insulin, Human Insulatard based on 0.2 units/kg. This is currently 11 unit subcutaneously to be administered in the morning, before breakfast. At last review her HbA1c was 46 mmol/mol. She has no other medical history of note. She lives at home while studying for A Levels. She has 6 younger siblings and both parents are non-English speaking. She is a non-smoker, non-drinker and denies use of recreational drugs. Provide a critical discussion of your future registrants’ role when identifying the legal requirements of amedication prescription prior to the administration of a drug . Describe, with reference to known evidence base and theory, the ” human factors ” which contribute to medication errors and strategies which might be employed to reduce the risk of a medication error occurring. Include discussion of learning from mistakes. Q3: You are required to administer the following medication: Insulin NovoRapid®. Describe and critically reflecton your role and the process involved in preparing this medication and equipment. The stock insulin isNovoRapid®100 units/mL ampule. Your answer should include reference to risk management, legislation, and national guidelines.

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."